ATAJECT DIN 02490900
Status: Marketed
Holder: GREY WOLF ANIMAL HEALTH INC
Health Canada record
| Active ingredient(s) | ATIPAMEZOLE HYDROCHLORIDE 5 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Intramuscular |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 22-Jan-2021 |
|---|
| Current status date | 22-Jan-2021 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Grey Wolf Animal Health Inc. — licence 3-002474, currently licensed, last inspection rating C (2022-11-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ATIPAMEZOLE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02237744 | ANTISEDAN | ORION CORPORATION | Solution | ATIPAMEZOLE HYDROCHLORIDE 5 MG | Marketed |
| 02491710 | ATIPAM | EUROVET ANIMAL HEALTH B.V. | Solution | ATIPAMEZOLE HYDROCHLORIDE 5 MG | Marketed |
| 02337207 | REVERTOR | MODERN VETERINARY THERAPEUTICS LLC | Solution | ATIPAMEZOLE HYDROCHLORIDE 5 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 22472 | 2019-07-29 | Abbreviated New Drug Submission (ANDS) | |
Request a quote for ATAJECT
How to read a Canadian DIN record